The Herbal Antidepressant That Is NOT Safe

A popular herbal antidepressant has dangerous side-effects.

A popular herbal antidepressant has dangerous side-effects.

Kratom, a herbal antidepressant also used for pain relief and other conditions, is NOT safe, research finds.

Kratom, which is a supplement derived from a southeast Asian tree, is used by some to treat opioid addiction.

Kratom is sold as a mood-enhancer, energy booster and pain-reliever.

However, a new analysis of the US National Poison Data System, finds it has a worrying range of side-effects.

The research suggests that kratom is not reasonably safe and poses a threat to public health.

The study of of 2,312 incidents of kratom exposure found that the most common side-effects of kratom were:

  • agitation (18.6 percent),
  • tachycardia, a racing heart (16.9 percent),
  • drowsiness (13.6 percent),
  • vomiting (11.2 percent),
  • and confusion (8.1 percent).

More serious side-effects were also reported:

  • seizure (6.1 percent),
  • withdrawal (6.1 percent),
  • hallucinations (4.8 percent),
  • respiratory depression (2.8 percent),
  • coma (2.3 percent),
  • and cardiac or respiratory arrest (0.6 percent).

The supplement was listed as a cause of death in the case of four people.

Kratom is classified as a dietary supplement, so not regulated by the FDA in the US.

The active ingredient of Kratom is mitragynine, which binds to opioid receptors in the brain.

This may cause a pain relieving and sedative effect.

Dr William Eggleston, the study’s first author, said:

“Although it is not as strong as some other prescription opioids, kratom does still act as an opioid in the body.

In larger doses, it can cause slowed breathing and sedation, meaning that patients can develop the same toxicity they would if using another opioid product.

It is also reported to cause seizures and liver toxicity.

Kratom may have a role in treating pain and opioid use disorder, but more research is needed on its safety and efficacy.

Our results suggest it should not be available as an herbal supplement.”

Kratom is already illegal, or only semi-legal in many countries, including the UK, Denmark, Finland, Thailand and Australia.

Some US states have banned the herb, including Alabama, Arkansas, Indiana, Rhode Island, Vermont, and Wisconsin.

The study was published in the journal Pharmacotherapy (Eggleston et al., 2019).

How To Prevent Depression Relapse Without Antidepressants (M)

Four out of five people with depression will relapse at some point without treatment.

Four out of five people with depression will relapse at some point without treatment.

Keep reading with a Membership

• Read members-only articles
• Adverts removed
• Cancel at any time
• 14 day money-back guarantee for new members

Antidepressants Have A Confusing Effect On Emotions

A little-known antidepressant side-effect on emotions and motivation.

A little-known antidepressant side-effect on emotions and motivation.

People taking antidepressants find it harder to identify their feelings, research finds.

The drugs may cause emotional blunting, lower levels of empathy and even apathy.

The difficulty identifying emotions and apathy could be two sides of the same coin.

SSRI antidepressants in particular are sometimes said to make people indifferent: apathetic towards their emotions and any activities.

People taking the drugs feel less motivation and less emotion — whether positive or negative.

For the study, 57 people taking antidepressants were compared to a control group of 441 people.

The results showed that people taking the antidepressants were more likely to have trouble identifying their feelings.

The study’s authors point out that their research doesn’t necessarily show that taking antidepressants causes this side-effect.

However, it is thought that up to one in five people taking antidepressants have emotional side-effects.

Some studies, though, suggest the rates of apathy and emotional blunting after taking SSRI antidepressants could be even higher, perhaps approaching 50%.

The antidepressants people were taking in the study were mostly SSRIs, which target the serotonin system and include most modern antidepressants such as Prozac, Zoloft, Paxil and many, many more.

Some were also taking older style tricyclic antidepressants, such as clomipramine.

The study was published in the journal Experimental and Clinical Psychopharmacology (Kajanoja et al., 2018).

Depression NOT Caused By Low Serotonin Levels, Large Review Finds (M)

About 90 percent of people believe that depression is caused by a chemical imbalance in the brain.

About 90 percent of people believe that depression is caused by a chemical imbalance in the brain.

Keep reading with a Membership

• Read members-only articles
• Adverts removed
• Cancel at any time
• 14 day money-back guarantee for new members

This Class Of Antidepressant Reduces COVID Deaths

The research found that people taking these antidepressants were 28 percent less likely to die of COVID.

The research found that people taking these antidepressants were 28 percent less likely to die of COVID.

SSRI antidepressants reduce the risk of dying from COVID, a large analysis finds.

Selective serotonin reuptake inhibitors, or SSRIs, include most modern antidepressants such as Prozac or Seroxat.

The research found that people taking fluoxetine, which is marketed under names such as Prozac, Sarafem and Adofen, were 28 percent less likely to die of COVID.

Another SSRI antidepressant called fluvoxamine was linked to a 26 percent reduction in the risk of dying from COVID.

Fluvoxamine is branded Luvox and mainly used in the US to treat OCD and social anxiety, and elsewhere for depression.

Dr Marina Sirota, study co-author, said:

“We can’t tell if the drugs are causing these effects, but the statistical analysis is showing significant association.

There’s power in the numbers.”

For the study, researchers analysed almost half-a-million health records.

The results showed that taking any kind of SSRI antidepressant was linked to an 8 percent reduced chance of dying from COVID.

The apparent protective effect was particularly strong for fluoxetine and fluvoxamine.

While the benefits are not as strong as those shown by new antivirals developed by Merck and Pfizer, the results are still significant.

Dr Tomiko Oskotsky, the study’s first author, said:

“The results are encouraging.

It’s important to find as many options as possible for treating any condition.

A particular drug or treatment may not work or be well tolerated by everyone.

Data from electronic medical records allow us to quickly look into existing drugs that could be repurposed for treating COVID-19 or other conditions.”

SSRIs have anti-inflammatory properties

A previous study found that fluvoxamine may reduce the risk of hospitalisation with COVID by 32 percent.

Fluvoxamine’s and other SSRI’s beneficial effect is thought to be due to its anti-inflammatory properties.

The drug may help to fight the so-called ‘cytokine storms’ which are a feature of severe COVID.

Cytokine storms are when the body’s immune system becomes overactive.

The study was published in JAMA Network Open (Oskotsky et al., 2021).

How Antidepressants Affect Long-Term Quality Of Life (M)

While antidepressants have been shown to reduce depression symptoms in the short-term, less research has looked at their long-term and wider effects.

While antidepressants have been shown to reduce depression symptoms in the short-term, less research has looked at their long-term and wider effects.

Keep reading with a Membership

• Read members-only articles
• Adverts removed
• Cancel at any time
• 14 day money-back guarantee for new members

Antidepressants: Pros And Cons And How They Should Be Prescribed (M)

About one-in-six people takes antidepressants, with the rate being 50 percent high among women.

About one-in-six people takes antidepressants, with the rate being 50 percent high among women.

Keep reading with a Membership

• Read members-only articles
• Adverts removed
• Cancel at any time
• 14 day money-back guarantee for new members

The Science of Antidepressants Is Based On Totally Backward Facts (M)

For 50 years scientists and the public alike have been completely wrong about the biological basis of depression.

For 50 years scientists and the public alike have been completely wrong about the biological basis of depression.

Keep reading with a Membership

• Read members-only articles
• Adverts removed
• Cancel at any time
• 14 day money-back guarantee for new members

COVID: An Antidepressant Reduces Hospitalisation Risk 32% (M)

The study found that the antidepressant reduced the risk of hospitalisation or emergency care by almost one-third.

The study found that the antidepressant reduced the risk of hospitalisation or emergency care by almost one-third.

Keep reading with a Membership

• Read members-only articles
• Adverts removed
• Cancel at any time
• 14 day money-back guarantee for new members

How Stopping Antidepressants Affects Relapse Risk (M)

Deciding whether to stay on antidepressants or come off them depends on balancing up the pros and cons.

Deciding whether to stay on antidepressants or come off them depends on balancing up the pros and cons.

Keep reading with a Membership

• Read members-only articles
• Adverts removed
• Cancel at any time
• 14 day money-back guarantee for new members

Get free email updates

Join the free PsyBlog mailing list. No spam, ever.